Fractyl Health (GUTS) Shares Outstanding (Diluted Average) (2023 - 2026)

Fractyl Health (GUTS) has 4 years of Shares Outstanding (Diluted Average) data on file, last reported at $158.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 224.34% year-over-year to $158.5 million; the trailing twelve-month figure through Mar 2026 stood at $158.5 million (up 224.34% YoY), and the FY2025 full-year result was $75.8 million, up 74.13% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $158.5 million, up from $75.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $158.5 million in Q1 2026 and bottomed at $2.1 million in Q1 2023.
• A 4-year average of $42.7 million and a median of $43.5 million in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) surged 2212.86% in 2024 and gained 13.07% in 2025, its largest moves.
• Tracing GUTS's Shares Outstanding (Diluted Average) over 4 years: stood at $2.1 million in 2023, then jumped by 1992.01% to $43.5 million in 2024, then surged by 74.13% to $75.8 million in 2025, then soared by 109.04% to $158.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $158.5 million, $75.8 million, and $54.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison